ELVN vs TER · $2.11B cap vs P/E 76, rev $2.61B
Enliven Therapeutics Inc. (ELVN) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Enliven Therapeutics Inc. (ELVN) is a biotechnology company listed on US.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
ELVN does not have a complete income-statement cache yet.
Latest reported TER revenue for 2026-06-28 was $2.61B. Net income was $773.4M. TER currently screens at market cap $63.96B and trailing P/E 75.7.
ELVN currently screens at market cap $2.11B. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the ELVN and TER stock pages for the full models.
Not investment advice.